Revenue (Quarterly) Chart

View Revenue (Quarterly) for EVKIF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue (Quarterly) Chart
Start Trial

Historical Revenue (Quarterly) Data

View and export this data back to 2007. Start Trial.
Date Value
June 30, 2026 4.526B
March 31, 2026 4.009B
December 31, 2025 3.961B
September 30, 2025 3.963B
June 30, 2025 3.966B
March 31, 2025 3.975B
December 31, 2024 3.839B
September 30, 2024 4.210B
June 30, 2024 4.231B
March 31, 2024 4.120B
December 31, 2023 3.877B
September 30, 2023 4.102B
June 30, 2023 4.229B
March 31, 2023 4.297B
December 31, 2022 4.427B
September 30, 2022 4.911B
June 30, 2022 5.079B
March 31, 2022 5.046B
December 31, 2021 4.675B
September 30, 2021 4.563B
June 30, 2021 4.384B
March 31, 2021 4.045B
December 31, 2020 3.831B
September 30, 2020 3.409B
June 30, 2020 3.113B
Date Value
March 31, 2020 3.573B
December 31, 2019 3.636B
September 30, 2019 3.593B
June 30, 2019 3.715B
March 31, 2019 3.732B
December 31, 2018 3.720B
September 30, 2018 3.893B
June 30, 2018 4.066B
March 31, 2018 3.991B
December 31, 2017 4.207B
September 30, 2017 4.174B
June 30, 2017 3.981B
March 31, 2017 3.875B
December 31, 2016 3.454B
September 30, 2016 3.531B
June 30, 2016 3.680B
March 31, 2016 3.424B
December 31, 2015 3.500B
September 30, 2015 3.740B
June 30, 2015 3.893B
March 31, 2015 3.850B
December 31, 2014 4.030B
September 30, 2014 4.299B
June 30, 2014 4.453B
March 31, 2014 4.386B

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (Quarterly) Range, Past 5 Years

View Revenue (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue (Quarterly) Benchmarks

View Revenue (Quarterly) Benchmarks
Start Trial
Alzchem Group AG 180.51M
BASF SE 20.01B
Covestro AG 3.393B
Lanxess AG 1.815B
Arq, Inc. 29.88M